fda approvals in cervical cancer, ovarian cancer, and cll, and more
Published 6 years ago • 210 plays • Length 9:08
Download video MP4
Download video MP3
Similar videos
-
11:34
fda approval in cll, recommendation in sts, partial hold on cervical cancer trial, and more
-
8:17
fda approvals in hcc and cervical cancer, breakthrough designation in lung cancer, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
10:41
fda approvals in ovarian cancer and for mec chemo, promising data in lung cancer, and more
-
4:31
nccn guidelines and fda approvals for treating ovarian cancer
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
7:01
fda approvals in ovarian cancer and merkel cell carcinoma
-
10:39
fda approvals in ovarian cancer, merkel cell carcinoma, itp, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
10:11
priority review designation in cervical cancer, odac recommendation in all, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
9:46
fda approval in cll, recommendation in nsclc, missed endpoint in gbm study, and more
-
1:04
dr. monk on the fda approval of pembrolizumab in cervical cancer
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
8:10
fda approval for cll, odac vote in lung cancer, european regulatory advances, and more
-
8:16
fda approvals in hcc and gastric cancer, odac panel splits on adjuvant rcc treatment, and more
Clip.africa.com - Privacy-policy